Results 141 to 150 of about 77,703 (269)

A Pilot Study of 18F‐rhPSMA‐7.3‐PET/MRI to Reduce Mischaracterization of Active Surveillance and Focal Therapy Candidates With Occult Higher Risk Disease

The Prostate, Volume 86, Issue 8, Page 865-871, June 2026.
ABSTRACT Introduction PSMA‐PET offers an opportunity to reduce the mischaracterization of disease in active surveillance (AS) and focal therapy (FT) candidates. We describe the results of a pilot clinical trial evaluating 18F‐radiohybrid(rh)PSMA‐7.3‐PET/MRI to detect occult adverse pathology among potential AS and FT candidates (NCT05852041).
Ridwan Alam, Derek Hesse, Nikki Hubbard, Emma McGarrity, Sai Kumar, Clayton Neill, Yutai Li, Nicole Handa, Hiten D. Patel, Edward M. Schaeffer, Hatice Savas, Ashley E. Ross   +11 more
wiley   +1 more source

Exploring the Gut‐Prostate Axis: Microbial Signatures Linked to Prostate Volume and Bladder Function

The Prostate, Volume 86, Issue 8, Page 900-910, June 2026.
ABSTRACT Background Benign prostatic hyperplasia (BPH) is a common urologic condition in aging men, often linked to systemic inflammation and metabolic dysfunction. Emerging evidence suggests that the gut microbiome may contribute to prostate health and disease.
Jonathan Surber, Marie Lork, Yasser Morsy, Michael Scharl, Daniel Stephan Engeler, Janine Langenauer, Lukas John Hefermehl, Anna Ebner, Basil Kaufmann, Manuela Hunziker, Daniel Eberli, Uwe Bieri, Cédric Poyet   +12 more
wiley   +1 more source

Awareness and Knowledge of Lower Urinary Tract Symptoms (LUTS) Among Male Adults in Primary Care Settings in Hong Kong: A Questionnaire‐Based Study

Trends in Urology &Men's Health, Volume 17, Issue 3, June 2026.
ABSTRACT This study aims to assess the awareness and knowledge level of lower urinary tract symptoms (LUTS) in male adults in primary care setting in Hong Kong and explore its relationship with the behavior of seeking medical help. This is a cross‐sectional questionnaire‐based study recruited male adults aged 40 years or older.
Lik Tai, Hei Lim Li
wiley   +1 more source

A single cell transcriptional profile of benign prostatic hyperplasia. [PDF]

Sci Rep
Unno R, Akutagawa J, Song H, Hui K, Chen YA, Pham JH, Lee J, Yang H, Huang FW, Chi T.   +9 more
europepmc   +1 more source

Spongiosolysis [PDF]

, 1987
Gilbert, P., Stief, Christian Georg
core   +1 more source

Restless Legs Syndrome in Patients With PMP22‐Related Neuropathies

Journal of the Peripheral Nervous System, Volume 31, Issue 2, June 2026.
ABSTRACT Background and Aims Restless legs syndrome (RLS) is frequently reported in peripheral neuropathies, but its prevalence and clinical correlates in Charcot–Marie–Tooth disease type 1A (CMT1A) and hereditary neuropathy with liability to pressure palsies (HNPP) remain poorly defined.
Bogdan Bjelica, Milorad Vujnic, Milica Vukojevic, Ivo Bozovic, Nikola Andrejic, Ivana Basta, Vidosava Rakocevic‐Stojanovic, Stojan Peric   +7 more
wiley   +1 more source

Minimally invasive treatments for benign prostatic hyperplasia: A narrative review. [PDF]

Medicine (Baltimore)
Zhang X, Liang T, Dong Y, Gao H.
europepmc   +1 more source

Bedside risk score for medical therapy failure in small‐volume BPH: Temporal validation

BJUI Compass, Volume 7, Issue 5, May 2026.
Abstract Purpose Medical therapy is the first‐line treatment for lower urinary tract symptoms (LUTS) secondary to benign prostatic hyperplasia (BPH). However, predictors of treatment failure in men with small prostate volume (<30 ml) remain poorly defined.
Numan Alam, Naveed Ahmad, Syed Hamzah Shirazi, Aftab Ahmed, Bilal Suria, Jamahid Ali, Muhammad Anas Ghazi, Elham Shenawa, Mirza Muhammad Hadeed Khawar   +8 more
wiley   +1 more source

Relation of Prostatic and Urinary Bladder Ultrasound Parameters in Patients With Benign Prostatic Hyperplasia. [PDF]

Health Sci Rep
Pokharel BP, Thapa NB, Singh J, Dangi Y, Singh DB.   +4 more
europepmc   +1 more source

Benign prostatic hyperplasia

BMJ, 1999
openaire   +3 more sources